Literature DB >> 17560903

Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.

Salleh Ibrahim1, Anupama Roychowdhury, Tay Khoon Hean.   

Abstract

BACKGROUND: Long-term survival after hepatectomy for hepatocellular carcinoma is still poor because of tumor recurrence especially in the liver remnant. The risk factors for intrahepatic recurrence after liver resection are studied in our cohort of patients.
METHODS: A retrospective analysis from a prospective database was performed on 76 consecutive successful hepatectomies for hepatocellular carcinoma.
RESULTS: Twenty-two patients had intrahepatic recurrence. The following were not found to be risk factors for recurrence: age, sex, race, number of segments resected, and mean operating time. By using multivariate analysis, serum aspartate transaminase level, more than 1 hepatocellular carcinoma nodule, and presence of tumor thrombi were found to be significant risk factors.
CONCLUSION: Patients who with these risk factors should undergo close follow-up to detect recurrence early; treatment with reresection, chemoembolization, or radiofrequency ablation can be considered.

Entities:  

Mesh:

Year:  2007        PMID: 17560903     DOI: 10.1016/j.amjsurg.2006.06.051

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.

Authors:  Wei-Feng Shen; Wei Zhong; Feng Xu; Tong Kan; Li Geng; Feng Xie; Cheng-Jun Sui; Jia-Mei Yang
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

2.  Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Yusuke Yamamoto; Hisashi Ikoma; Ryo Morimura; Hirotaka Konishi; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chouhei Sakakura; Toshiya Ochiai; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

3.  Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver.

Authors:  Mohamed Abdel-Wahab; Tarek Salah El-Husseiny; Ehab El Hanafy; Mohamed El Shobary; Emad Hamdy
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

4.  Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma.

Authors:  Jiarui Jiang; Guoqing Liu; Xiongying Miao; Songwen Hua; Dewu Zhong
Journal:  Exp Ther Med       Date:  2011-03-18       Impact factor: 2.447

5.  Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Yi-Ming Tao; Xiang Ding
Journal:  Dig Dis Sci       Date:  2008-07-01       Impact factor: 3.199

6.  Intraoperative ultrasound patterns predict recurrences after surgical treatments for hepatocellular carcinoma().

Authors:  R Santambrogio; M Costa; D Strada; M Barabino; M Conti; E Bertolini; M Zuin; E Opocher
Journal:  J Ultrasound       Date:  2010-11-11

7.  Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Authors:  Kit-Fai Lee; Charing C N Chong; Anthony K W Fong; Andrew K Y Fung; Hon-Ting Lok; Yue-Sun Cheung; John Wong; Paul B S Lai
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

8.  Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection.

Authors:  Myung Hee Yoon; Young Il Choi; Kwang Kuk Park; Dong Hoon Shin; Chung Han Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-05-31

9.  Long-term survival after resection of hepatocellular carcinoma.

Authors:  Ki Hoon Kim; Young-Kil Choi
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-08-31

Review 10.  Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review.

Authors:  Shu Yang; Qi Lin; Wei Lin; Weilei Hu; Guosheng Wang
Journal:  World J Surg Oncol       Date:  2016-06-09       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.